Evaluation of tumor infiltrating lymphocytes as a prognostic biomarker in patients with ductal carcinoma in situ of the breast.
Camila Vitola PasettoFernando Nalesso AguiarMarcella Bassan PeixotoMaíra Teixeira DóriaBruna Salani MotaJonathan Yugo MaesakaJosé Roberto FilassiEdmund Chada BaracatRodrigo GoncalvesPublished in: Breast cancer research and treatment (2024)
In our cohort, a high percentage of TILs (≥ 17%) and the presence of comedonecrosis were independently associated with DCIS recurrence.
Keyphrases